Cry features of healthy neonates who passed their newborn hearing screening vs. those who did not.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
May 2021
Historique:
received: 10 12 2020
revised: 09 02 2021
accepted: 18 03 2021
pubmed: 3 4 2021
medline: 24 6 2021
entrez: 2 4 2021
Statut: ppublish

Résumé

Temporal and fundamental frequency (fo) variations in infant cries provide critical insights into the maturity of vocal control and hearing performances. Earlier research has examined the use of vocalisation properties (in addition to hearing tests) to identify infants at risk of hearing impairment. The aim of this study was to determine whether such an approach could be suitable for neonates. To investigate this, we recruited 74 healthy neonates within their first week of life as our participants, assigning them to either a group that passed the ABR-based NHS (PG, N = 36) or a group that did not, but were diagnosed as normally hearing in follow-up check at 3 months of life, a so-called false-positive group (NPG, N = 36). Spontaneously uttered cries (N = 2330) were recorded and analysed quantitatively. The duration, minimum, maximum and mean fo, as well as two variability measures (fo range, fo sigma), were calculated for each cry utterance, averaged for individual neonates, and compared between the groups. A multiple analysis of variance (MANOVA) revealed no significant effects. This confirms that cry features reflecting vocal control do not differ between healthy neonates with normal hearing, irrespective of the outcome of their initial NHS. Healthy neonates who do not pass the NHS but are normal hearing in the follow-up (false positive cases) have the same cry properties as those with normal hearing who do. This is an essential prerequisite to justify the research strategy of incorporating vocal analysis into NHS to complement ABR measures in identifying hearing-impaired newborns.

Identifiants

pubmed: 33799102
pii: S0165-5876(21)00082-3
doi: 10.1016/j.ijporl.2021.110689
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110689

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Kathleen Wermke (K)

Center for Pre-Speech Development and Developmental Disorders, Department of Orthodontics, University of Würzburg, Germany. Electronic address: wermke_k@ukw.de.

Mario Cebulla (M)

Comprehensive Hearing Center (CHC), Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University Hospital, University of Würzburg, Germany.

Vivien Salinger (V)

Center for Pre-Speech Development and Developmental Disorders, Department of Orthodontics, University of Würzburg, Germany.

Veronique Ross (V)

Center for Pre-Speech Development and Developmental Disorders, Department of Orthodontics, University of Würzburg, Germany.

Johannes Wirbelauer (J)

University Children's Hospital, Department of Neonatology, University of Würzburg, Germany.

Wafaa Shehata-Dieler (W)

Comprehensive Hearing Center (CHC), Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University Hospital, University of Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH